API Product and Service Directory | Pharmaceutical Outsourcing

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate
Monday, August 03, 2026
Polpharma Biologics announced that the FDA and the EMA have accepted for review the Biologics License Application (BLA) and Marketing Authorization Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio® (vedolizumab) lyophilized... read more
Codis Completes Nottingham Deal to Expand Europe’s Spray Dry Network
Monday, August 03, 2026
Codis has completed its acquisition of Catalent’s Nottingham, UK facility, a move that expands the company’s integrated spray dry offering in Europe and adds oral solid dose development and small-scale commercial manufacturing capabilities. read more
Genezen, Raiden Science Foundation Partner on UBA5 Gene Therapy Manufacturing
Monday, August 03, 2026
Genezen and the Raiden Science Foundation have announced a manufacturing partnership for an AAV9 gene replacement therapy for UBA5 disorder, moving the program closer to a first-in-human clinical trial. read more
Resilience and Lilly Invest $750M to Increase U.S.-Manufactured Medicine Supply
Monday, August 03, 2026
Resilience announced it has expanded its strategic partnership with Eli Lilly and Company to increase U.S. production of critical medicines featuring new pharmaceutical manufacturing investments in Ohio. read more
Piramal Pharma Starts FY27 With 17% Revenue Growth, Higher EBITDA
Thursday, July 30, 2026
Piramal Pharma said it began FY27 with stronger revenue and margin expansion, driven by broad-based growth across its contract development and manufacturing, complex hospital generics and consumer healthcare businesses. read more